Codethink, Ltd. Joins Eclipse Foundation and Eclipse SDV Working Group as Strategic Member to Advance Trustable Software Collaboration
7.1.2025 17:00:00 EET | Business Wire | Press release
Codethink, Ltd., a global leader in software engineering services and solutions, today announced its membership in the Eclipse Foundation and the Eclipse SDV Working Group as a Strategic Member. This milestone reflects Codethink’s commitment to driving innovation and industry standards in the emerging field of trustable software.
As part of its membership, Codethink will collaborate with the Eclipse Foundation and its global network of members to advance the concept of trustable software—software that is auditable, transparent, and suitable for use in critical systems and supply chains. In addition, Codethink will contribute key technologies and intellectual property from its Trustable Software portfolio to accelerate industry progress and stimulate innovation.
“Codethink is honoured to join the Eclipse Foundation and the Eclipse SDV Working Group as a Strategic Member,” said Paul Sherwood, Chairman of Codethink, Ltd. “We believe trustable software is essential to the secure and reliable operation of modern digital systems. By contributing our expertise and collaborating with industry leaders, we are paving the way for more transparent and reliable software solutions across the globe.”
The Eclipse Foundation welcomed Codethink’s decision to join its strategic membership ranks. “Codethink’s leadership in trustable software development brings critical capabilities to our community,” said Mike Milinkovich, Executive Director of the Eclipse Foundation. “Their contributions will further strengthen our collective efforts to ensure transparency, auditability, and trust in software systems.”
Codethink’s collaboration will benefit from the expertise of key partner exida, the world’s leading product certification and knowledge company specializing in automation system safety, alarm management, cybersecurity, and availability.
"Codethink's trustable model is a much-needed upgrade to the underlying principles of functional safety and cybersecurity designed for modern large-scale very complex software engineering and a best practice suitable for the architectures and deployments in use now and the future," said Jonathan Moore, director, advanced systems, exida LLC. “We look forward to collaborating on frameworks and standards that will set new benchmarks for software certification and assurance.”
Codethink’s membership with the Eclipse Foundation marks a significant step in fostering global industry collaboration to address the growing need for transparent, auditable, safe and secure software solutions.
For more information, visit www.codethink.co.uk or www.eclipse.org.
About Codethink
Codethink is a world-class provider of critical, high-performance software projects and solutions for international-scale companies in a range of industries including Automotive, Finance, Medical, and IoT. Headquartered in Manchester, UK, Codethink has pioneered software industry thinking around concepts of trustable software, working to improve the quality of software engineering.
About the Eclipse Foundation
The Eclipse Foundation provides our global community of individuals and organisations with a business-friendly environment for open source software collaboration and innovation. We host the Eclipse IDE, Adoptium, Software Defined Vehicle, Jakarta EE, and over 420+ open source projects, including runtimes, tools, specifications, and frameworks for cloud and edge applications, IoT, AI, automotive, systems engineering, open processor designs, and many others. Headquartered in Brussels, Belgium, the Eclipse Foundation is an international non-profit association supported by over 385 members. To learn more, follow us on X, LinkedIn or visit eclipse.org.
About exida
exida is a certification and research firm specializing in safety critical/high availability automation systems, control system cybersecurity, and alarm management. exida has performed more process control certifications and assessments than any other company worldwide. exida’s main offices are located in Sellersville, Pa., USA, and Munich, Germany and has worldwide operations with service centers in Brazil, Canada, Mexico, Netherlands, and New Zealand, Singapore, Japan, South Africa, and the United Kingdom.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250107724841/en/
Contacts
Media:
Amanda Keane
Vice President, Racepoint Global
akeane@racepointglobal.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Imagine Dragons to Perform at Abu Dhabi Grand Prix21.5.2026 18:51:00 EEST | Press release
Ethara, organiser of the Formula 1 Etihad Airways Abu Dhabi Grand Prix, have announced that one of the world’s biggest bands, Imagine Dragons, will headline the Saturday After-Race Concerts at the F1 Season Finale in Abu Dhabi. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521214839/en/ Imagine Dragons to perform at Formula 1 Etihad Airways Abu Dhabi Grand Prix (Photo: AETOSWire) The announcement is another landmark moment for the Abu Dhabi Grand Prix, whose thrilling Yasalam presented by e& fan entertainment offering has become synonymous with the F1 Championship finale in Abu Dhabi and is recognised as one of the most compelling sports and entertainment crossovers globally. The global chart-toppers join Lewis Capaldi and Zara Larsson, who are set to kick off a blockbuster line-up of performances on Yas Island on Thursday, 3 December, with more major international artists to be revealed. With their popular top hits, Ima
Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 17:25:00 EEST | Press release
Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensuring your investment is delivering.” The rapid growth of the residential solar market created a growing population of “orphaned” solar sy
Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 15:05:00 EEST | Press release
A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is designed to interpret cardiac MRI scans by connecting moving images of the heart with corresponding clinical radio
The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 15:00:00 EEST | Press release
Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The research challenges long-held assumptions about media value, showing that not all impressions are equal. Live sports rem
Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 15:00:00 EEST | Press release
Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer cell killing activity,” said David Weinreich, MD, MBA, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck. “The Phase 3 study and the enrollment of the first patient with Precem-TcT build on the Company’s more than 20 years of expertise in colorectal cancer, and highlight our commitment to advancing differentiated ADCs for heavily pretreated patients with limited treatment options.” The PROCEADE®-CRC-03 study
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom